COVID-19 Vaccine: The End of the Epidemic is Within Reach

Share on Facebook
Share on Twitter
Share on
LinkedIn
+

Join Host Joe Selvaggi and Virologist and Investor Dr. Peter Kolchinsky as they discuss the rapid development, efficacy, and rollout of the newly approved COVID-19 vaccines.

Guest:

Peter Kolchinsky, Ph.D. is a biotechnology investor and a scientist. He co-founded and runs the Boston-based investment firm RA Capital Management; writes and teaches about biomedical entrepreneurship and its potential to transform global health; serves on the boards of several public and private drug development companies; and lives in Massachusetts with his historian/equestrian wife, strong-willed children, and reasonably well-trained dog. In addition to The Great American Drug Deal, he is the author of The Entrepreneur’s Guide to a Biotech Startup. Peter served on the Board of Global Science and Technology for the National Academy of Sciences and writes about the biotech social contract. He holds a BA from Cornell University and a Ph.D. in Virology from Harvard University.

 

Get new episodes of Hubwonk in your inbox!

Related Posts:

COVID-19 Roundup from Pioneer: Antibodies & immunity; Talking about WHO; Telecommuting Survey Results; Mapping COVID – Update; & more!

/
Pioneer staff share their top picks for COVID-19 stories highlighting useful resources, best practices, and questions we should be asking our public and private sector leaders.

Even for the most remote part of Massachusetts (Franklin County), it’s far from business as usual

/
The Connecticut River valley is home to some of the most productive…

Hubwonk Ep. 8: Who is WHO? COVID-19, Massachusetts, and the unhealthy World Health Organization

/
Hubwonk host Joe Selvaggi and Pioneer Healthcare Senior Fellow Josh Archambault are joined by Hoover Institution’s Dr. Lanhee Chen to discuss the role that the World Health Organization (WHO) plays, what dysfunction may have contributed to the scale of the COVID-19 pandemic, and what steps can be taken to bring back transparency and trust.

Study: Safely Reopening Office Buildings Will Require Planning, Innovation

/
Safely bringing employees back into workplaces presents a significant challenge for employers located in office buildings, particularly when it comes to elevator operations and building entry and exit.  To address the challenge, managers must develop plans to control the flow of workers, according to a new study published by Pioneer Institute.

Acclaimed Poet & Former NEA Chairman Dana Gioia on Poetry & Arts Education

/
This week on “The Learning Curve,” Cara and Gerard are joined by Dana Gioia, a poet, writer, and the former Chairman of the National Endowment for the Arts, to talk about why the arts are so pivotal to the intellectual and civic development of America’s K-12 schoolchildren.

38.8 percent of the Massachusetts workforce and 28.3 percent of the U.S. workforce have filed unemployment claims over the past ten weeks.

/
Data released today by the U.S. Department of Labor shows that 38.8 percent of the Massachusetts workforce and 28.3 percent of the U.S. workforce have filed unemployment claims since the COVID-19 unemployment surge began ten weeks ago.

Once anchored by higher education, Hampshire County, MA finds itself out of work after a cancelled semester

/
The 38,000 college and university students at the Five College…

In Hampden County, COVID-19 exacerbates a stark employment divide between urban and rural areas

/
Hampden County, Massachusetts, home of Western New England’s…

Study: Officials Must Address Basic Questions to Improve Public School Computer Science Education

Even as the COVID-19 pandemic has further transitioned education towards electronic devices, computer science education in K-12 public schools around the country faces a number of daunting challenges, according to a new study published by Pioneer Institute.

Hubwonk Ep. 7: Covid Testing: What went wrong, where we are & when we’ll get closer to normalcy

/
https://www.podtrac.com/pts/redirect.mp3/chtbl.com/track/G45992/feeds.soundcloud.com/stream/828394294-pioneerinstitute-hubwonk-ep-7-covid-testing-what-went-wrong-where-we-are-when-well-get-closer-to-normalcy.mp3 Join…

Survey Suggests Demand for Telecommuting After COVID-19 Crisis

Citing an avoidance of the commute and more flexible scheduling, nearly 63 percent of respondents to Pioneer Institute’s survey, “Will You Commute To Work When The COVID-19 Crisis Is Over?” expressed a preference to work from home one day a week, and a plurality preferred two to three days a week, even after a COVID-19 vaccine is available. Respondents cite social isolation as the biggest drawback of remote work. The survey was conducted from April 22nd to May 15th, and received responses from over 700 individuals.

It’s Time for the MBTA to Actively Engage Riders to Understand Their Commuting Plans

/
The MBTA should conduct a survey of mTicket app users regarding their future plans. Some may never work in offices again. Some will certainly do some workdays in the office and some at home. Others will be in offices and back to business as usual at some point. Using their responses, the T can calculate ridership and determine projected revenue.

Homeschooling Expert Kerry McDonald on Harvard Law Professor Controversy & COVID

/
This week on “The Learning Curve,” Cara and Gerard are happy to be joined by Kerry McDonald, a homeschooling expert and Senior Fellow at the Foundation for Economic Education, on the major lessons we all should be learning from this educational moment, now that COVID has turned most of America’s 50 million schoolchildren and their families into "homeschoolers."

32.9 percent of the Massachusetts workforce and 26.2 percent of the U.S. workforce have filed unemployment claims over the past nine weeks.

/
Data released today by the U.S. Department of the shows that 33.0 percent of the Massachusetts workforce and 26.2 percent of the U.S. workforce have filed unemployment claims since the COVID-19 unemployment surge began nine weeks ago.

Study Finds Pandemic Likely to Negatively Impact Biopharmaceutical Sector

Contrary to conventional wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a new Pioneer Institute study finds many companies will emerge from the pandemic commercially weaker, dealing with delays in new product launches and with fewer resources to invest in research and development.

“Every Action has an Equal and Opposite Reaction”: 8 K-12 Science Resources During COVID-19

/
The fourth in Pioneer’s ongoing series of blogs on curricular resources for parents, families, and teachers during COVID-19 focuses on science education.

COVID-19 Roundup from Pioneer: The race for a vaccine; Unemployment Tracker; Reopening reactions; Grading BPS on remote learning; Holyoke Soldiers’ Home understaffing; & more!

/
Pioneer staff share their top picks for COVID-19 stories highlighting useful resources, best practices, and questions we should be asking our public and private sector leaders.

In The Era Of COVID-19, Mass. Needs To Get Long-Term Care Right

/
This op-ed originally appeared in WGBH News. In much of the…